CClinicalTrials.gg
Sign In
CompletedNCT04313569Updated Mar 20, 2020

Arthroscopic Versus Conservative Treatment of Degenerative Meniscal Tear in Middle Aged Patients in Regard to Pain & Knee Function

An interventional study of Arthroscopic menisctomy in Knee Pain Chronic, sponsored by Hawler Medical University. Completed at 1 site in Iraq. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-03-20.

Sponsored by Hawler Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Aug 2017, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

The study is prospective comparative study, conducted in Erbil teaching hospital on 60 patients, their age ranging between 40 and 60 years. All were clinically diagnosed to have degenerative medial meniscal tear then confirmed by MRI. Thirty patients were treated conservatively, thirty patients were treated arthroscopically.

02

Conditions studied

  • Knee Pain Chronic

Keywords

  • Degenerative meniscal tear
  • arthroscopic partial meniscectomy
  • conservative treatment
  • medial meniscal tear
03

In context

Lead sponsor

Hawler Medical University is the lead sponsor of 56 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Atraumatic continuous pain in medial aspect of knee affecting daily activities, for more than one month despite the treatment of general physician.
  2. Grade 3 degenerative tear of medial meniscus approved on MRI.

Exclusion criteria

Exclusion Criteria:

  1. Meniscal tear due to trauma.
  2. Any rheumatologic knee disease.
  3. MRI showing ligament injury, loose bodies, tumors and osteochondral defects.
  4. Former surgery of knee and lower limb fractures in the last year.
  5. Knee joints with osteoarthritis graded 2 or more according to Kellgren-Lawrence scale (Kellgren and Lawrence, 1957) on weight-bearing knee x-ray.
  6. Lateral meniscus tear.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    Conservative treatment

    Use of medications, like analgesic, muscle relaxants, non-steroidal anti-inflammatory drugs (NSAID) and local painkillers, depending on the patient condition, and physiotherapy, lifestyle and daily activity modification, patient education about positioning of the knee

  • Other
    Arthroscopic menisctomy

    Procedure: Arthroscopic menisctomy

Interventions

  • ProcedureArthroscopic menisctomy

    Arthroscopic medial menisctomy

06

What researchers measure

Primary outcomes

  1. Lysholm Knee Scoring Scale

    Lysholm Knee score scale has (8) parts (swelling, pain, squatting, support, stair climbing, limping, locking and instability). Score of 100 means no problems in knee.

    Time frame: All patients were reviewed and evaluated one year, by Lysholm score

  2. Visual analogue score

    Ten points Visual Analogue Score scale used in order to meassure the severity of knee pain during the study. Zero meaning no pain while 10 meaning the most severe pain

    Time frame: All patients were reviewed and evaluated one year, by Visual Analogue score scales

07

Study locations

1 site
  • Sherwan Hamawandi
    Erbil, 44001, Iraq
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04313569
Lead sponsor
Hawler Medical University
Responsible party
Sherwan Ahmed Ali Hamawandi (Assistant professor of orthopedic surgery, Hawler Medical University) — Principal investigator
First posted
Mar 18, 2020
Start date
Aug 1, 2017
Primary completion
Sep 1, 2019
Completion
Sep 30, 2019
Last update
Mar 20, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Hawler Medical University

Start the discussion